Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z)

Jeonghyeon Moon; Seon yeong Lee; Jeong Won Choi; A. Ram Lee; Jin Hee Yoo; Su Jin Moon; Sung Hwan Park; Mi La Cho

doi:10.1186/s12967-021-02916-0

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z)

Jeonghyeon Moon
, Seon yeong Lee
, Jeong Won Choi
, A. Ram Lee
, Jin Hee Yoo
, Su Jin Moon
, Sung Hwan Park
, Mi La Cho

Catholic University of Korea
The Catholic University of Korea, College of Medicine

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the original publication [1] there was an incorrect funding section. The incorrect and correct funding information is published in this correction article. The original article has been updated.

Original language	English
Article number	266
Journal	Journal of Translational Medicine
Volume	19
Issue number	1
DOIs	https://doi.org/10.1186/s12967-021-02916-0
State	Published - Dec 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s).

Access to Document

10.1186/s12967-021-02916-0

Fingerprint

Dive into the research topics of 'Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z)'. Together they form a unique fingerprint.

Cite this

Moon, J., Lee, S. Y., Choi, J. W., Lee, A. R., Yoo, J. H., Moon, S. J., Park, S. H., & Cho, M. L. (2021). Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z). Journal of Translational Medicine, 19(1), Article 266. https://doi.org/10.1186/s12967-021-02916-0

@article{b9249a0ab7f64e8d9a7e653fed466c71,

title = "Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z)",

abstract = "In the original publication [1] there was an incorrect funding section. The incorrect and correct funding information is published in this correction article. The original article has been updated.",

author = "Jeonghyeon Moon and Lee, \{Seon yeong\} and Choi, \{Jeong Won\} and Lee, \{A. Ram\} and Yoo, \{Jin Hee\} and Moon, \{Su Jin\} and Park, \{Sung Hwan\} and Cho, \{Mi La\}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1186/s12967-021-02916-0",

language = "English",

volume = "19",

journal = "Journal of Translational Medicine",

issn = "1479-5876",

publisher = "BioMed Central Ltd.",

number = "1",

}

Moon, J, Lee, SY, Choi, JW, Lee, AR, Yoo, JH, Moon, SJ , Park, SH & Cho, ML 2021, 'Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z)', Journal of Translational Medicine, vol. 19, no. 1, 266. https://doi.org/10.1186/s12967-021-02916-0

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z). / Moon, Jeonghyeon; Lee, Seon yeong; Choi, Jeong Won et al.
In: Journal of Translational Medicine, Vol. 19, No. 1, 266, 12.2021.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z)

AU - Moon, Jeonghyeon

AU - Lee, Seon yeong

AU - Choi, Jeong Won

AU - Lee, A. Ram

AU - Yoo, Jin Hee

AU - Moon, Su Jin

AU - Park, Sung Hwan

AU - Cho, Mi La

PY - 2021/12

Y1 - 2021/12

N2 - In the original publication [1] there was an incorrect funding section. The incorrect and correct funding information is published in this correction article. The original article has been updated.

AB - In the original publication [1] there was an incorrect funding section. The incorrect and correct funding information is published in this correction article. The original article has been updated.

UR - https://www.scopus.com/pages/publications/85108985431

U2 - 10.1186/s12967-021-02916-0

DO - 10.1186/s12967-021-02916-0

M3 - Comment/debate

C2 - 34154617

AN - SCOPUS:85108985431

SN - 1479-5876

VL - 19

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

IS - 1

M1 - 266

ER -

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts (Journal of Translational Medicine, (2021), 19, 1, (192), 10.1186/s12967-021-02860-z)

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this